All In MedTech

Device Trial Radar · NCT04862156

WP02 Continued Access Study

Continued Access Protocol Study for the Use of the OrganOx Metra Normothermic Machine Perfusion Device in Human Liver Transplantation

Last checked: Nov 20, 2026Latest source record: Apr 15, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registry

Status

Terminated

Enrollment

19

Actual

Start

Oct 10, 2021

Primary completion

Jul 31, 2022

Study completion Jul 7, 2023

Sponsor

Lead sponsor
OrganOx Ltd.Not on our public-company list
Sponsor type
Industry
Collaborators
North American Science Associates Ltd.
First posted
Apr 27, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The single-arm continued access phase will be used to collect additional effectiveness and safety data to support the objectives and outcomes of the original IDE pivotal study.

Conditions

  • Liver Transplantation

Interventions

  • Normothermic Machine Perfusion (NMP)Device

    Storage and transportation of the donated liver using the OrganOx metra device.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of Early Allograft Dysfunction (EAD)Time frame: 7 days

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • University of Colorado

    Aurora, Colorado

6 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.